Showing results (131-140 of 387) with videos related to
Sort By:
Pageof 39
The Lancet. Neurology|December 23, 2021
The neuropsychiatry of Parkinson's disease: advances and challengesDaniel Weintraub, Dag Aarsland, Kallol Ray Chaudhuri, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 17, 2024
Validation of the Italian version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS) in an Italian Parkinson's disease cohortGianpaolo Maggi, Carmine Vitale, Chiara Giacobbe, et al.The Clinical Neuropsychologist|December 14, 2011
Medication management and neuropsychological performance in Parkinson's diseaseKevin J Manning, Christina Clarke, Alan Lorry, et al.Movement Disorders Clinical Practice|October 27, 2018
Memantine and Cognition in Parkinson's Disease Dementia/Dementia With Lewy Bodies: A Meta-AnalysisLaura Brennan, Alexander Pantelyat, John E Duda, et al.International Journal of Geriatric Psychiatry|November 30, 2006
Depression in veterans with Parkinson's disease: frequency, co-morbidity, and healthcare utilizationPeijun Chen, Helen C Kales, Daniel Weintraub, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 27, 2007
Long-term follow-up of impulse control disorders in Parkinson's diseaseEugenia Mamikonyan, Andrew D Siderowf, John E Duda, et al.Journal of Parkinson'S Disease|April 11, 2016
Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx)Jori E Fleisher, Nabila A Dahodwala, Sharon X Xie, et al.JAMA Neurology|March 22, 2016
Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson DiseaseDaniel Weintraub, Claire Chiang, Hyungjin Myra Kim, et al.Frontiers in Neuroscience|February 24, 2017
Narrative Organization Deficit in Lewy Body Disorders Is Related to Alzheimer PathologyMurray Grossman, David J Irwin, Charles Jester, et al.Neurology|July 20, 2014
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled studyKimberly Papay, Sharon X Xie, Matthew Stern, et al.Pageof 39